Analyst Price Targets — EVOK
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 28, 2024 2:21 pm | Yale Jen | Laidlaw | $18.00 | $7.08 | StreetInsider | Laidlaw Reiterates Buy Rating on Evoke Pharma (EVOK) |
Latest News for EVOK
Evoke PLC (LSE:EVOK), the gambling group that owns William Hill, 888 and Mr Green, has agreed to a £243 million all-share takeover by Bally's Intralot, the Athens-listed lottery and gaming operator, sending its shares 16% higher to 46.45p. The recommended offer values Evoke at 52p per share and includes a partial cash alternative.
Evoke shareholders will be entitled to receive 0.537 new Intralot shares for each Evoke share. The deal is expected completed the deal by the first quarter of 2027.
William Hill UK owner Evoke said on Friday it had agreed to be acquired by Bally's Intralot S.A. in a recommended all-share deal valuing the company at about £243 million ($326.23 million).
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVOK.
U.S. House Trading
No House trades found for EVOK.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.